Trump’s surprise 50% tariff hike is forcing Indian exporters to rethink strategies and move production to lower-tariff countries https://t.co/O1wkvddmCo ...

Financial Data and Key Metrics Changes - Total reported revenue grew by 9% in the first quarter, with constant currency organic revenue increasing by 8% driven by volume and a 230 basis point price increase [7][9] - Gross margin increased by 20 basis points to 45.3%, while EBIT margin rose by 50 basis points to 22.8% of revenue compared to the previous year [8][9] - Adjusted earnings per diluted share improved by 15% to $2.34, with net income from continuing operations at $231.2 million [9][10] - Free cash flow for the fiscal year 2026 was reported at $327 million, with an increase in outlook for free cash flow raised to $820 million [10][18] Business Line Data and Key Metrics Changes - In the Healthcare segment, constant currency organic revenue grew by 8%, with capital equipment revenue increasing by 6% and service revenue growing by 13% [14] - The AST segment saw a 10% growth in constant currency organic revenue, with services growing by 12% and EBIT margins increasing by 150 basis points to 48.6% [15] - Life Sciences group reported a 4% increase in constant currency organic revenue, driven by an 8% growth in consumables [16] Market Data and Key Metrics Changes - The backlog for Healthcare capital equipment was reported at over $400 million, indicating strong underlying order growth of 14% [14] - Life Sciences backlog increased by over 50% to $111 million, reflecting a recovery in capital orders after a previous slowdown [16][30] Company Strategy and Development Direction - The company is focused on maintaining consistent dividend growth, announcing a 10% increase to $0.63 per quarter [10] - Management emphasized the importance of strategic oversight and financial leadership during the CFO transition, indicating a commitment to continued growth and stability [11][13] - The company is actively pursuing M&A opportunities while also considering stock buybacks to offset dilution [44][46] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong order growth and backlog, indicating a positive outlook for revenue despite potential challenges in the healthcare payment landscape [42][61] - The company updated its revenue growth outlook to approximately 8% to 9%, reflecting favorable currency impacts, while maintaining a constant currency organic revenue growth forecast of 6% to 7% [17][18] - Management acknowledged the complexities in the bioprocessing market but noted a return to normal volume trajectories [28][30] Other Important Information - The company is experiencing increased costs related to employee healthcare benefits due to higher utilization rates [38] - The effective tax rate for the quarter was reported at 23.5%, with no anticipated changes [18] Q&A Session Summary Question: Revised tariff estimate details - The increase in tariff expectations was driven by higher tariffs on metals and changes in EU tariffs [22] Question: Maintaining organic expectations for AST - The conservative outlook is due to potential fluctuations in manufacturing positions from customers [24] Question: Update on bioprocessing market - Recent volumes have been consistent, indicating a return to normal trajectories [28] Question: Life Sciences segment backlog increase - The increase is attributed to a recovery from previous capital order slowdowns [30] Question: Comments on low temp sterilization market - The company has not seen a slowdown and feels confident in its market position [35] Question: Employee healthcare costs - Increased costs are primarily due to higher utilization of employee healthcare benefits [38] Question: Capital demand environment and order growth - Strong orders in both healthcare and life sciences sectors contribute to confidence in revenue guidance [42] Question: Future cash allocation strategies - The company remains open to M&A opportunities while also considering stock buybacks [44][46] Question: Impact of regulatory changes on EO facilities - The company did not apply for regulatory relief as it has already met compliance standards [56] Question: Hospital outlook and OB3 impact - Management views the situation as a payment reimbursement issue rather than a demand issue [61] Question: FX impact on profitability - The company is largely operationally hedged against FX impacts [63]

Trump’s chip tariff threat didn’t rattle investors — most major firms are already building in the US or expect exemptions https://t.co/V1di9CU8Yk ...

Is there anything in here that actually isn't as extreme as expected. Just looking at the investor reaction in the broader market, it's not so bad. Well, Shnali, it was widely expected.President Trump said that we could expect this so-called secondary tariff to be implemented on India within the next 24 hours. That was yesterday. And now we got this post on X outlining this new executive order that he signed for an additional 25% tariff against India.And according to the executive order, this will stack on ...

Facing a 50% tariff from Trump, India is weighing trade concessions to keep talks alive — including in agriculture https://t.co/sHsUAAC9Pr ...

This afternoon, we're pleased to welcome to the White House one of the great and most esteemed business leaders and geniuses and innovators anywhere in the world, Apple CEO Tim Cook. Amazing job. Thanks as well to Secretary of the Treasury Scott Bessant and Secretary of Commerce Howard Lutnik for being here wherever you may be.>> Oh, there you are. Hello, fellas. I missed you.Today, Apple is announcing that it will invest $600 billion dollar, that's with a B, in the United States over the next four years. T ...

Donald Trump has slapped an extra 25% tariff on India, which he accuses of funding Russia’s “war machine”. A bill vowing levies of up to 500% on countries that buy Russian oil is making its way through Congress. The tariffs will hurt https://t.co/vjlXjX6vdp ...

Differing interpretations of tariff-stacking in the US-Japan trade deal came to the fore on Thursday, as Japan’s chief negotiator visits Washington to press for follow-through on a pledge to cut a levy on car imports to 15% https://t.co/EA11AOpv4w ...

We're going to be putting a very large uh tariff on chips and semiconductors. But the good news for companies like Apple is if you're building in the United States or have committed to build without question committed to build in the United States, there will be no charge. In other words, we're not going to be charging.So, a lot of countries, a lot of companies are leaving various other places and they're coming to the United States. So in other words, we'll be putting a tariff of approximately 100% on chip ...

The White House said Wednesday that it will implement the tariff on Aug. 27 because India continues to purchase oil from Russia. https://t.co/uXCksdwmp8 ...